Search - sphingotec.com

11. The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure

The diagnostic company SphingoTec GmbH announces new evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery…

12. SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India

SphingoTec and Rivaara Labs today announced that they have entered into a multi-year distribution agreement for the commercialization of SphingoTec’s point of care diagnostic solutions in the Indian…

13. Proenkephalin (penKid) sheds light on the diagnostic blind spots in assessing acute kidney injury in children

SphingoTec announces that its kidney function biomarker penKid is reliably identifying AKI in infants, offering a solution to the shortcomings in pediatric critical care. AKI is mostly diagnosed too…

14. www.sphingotec.com

Follow our Journey on Social Media View all Events View all News Events & Expos Latest News Subscribe to our Newsletter Follow the link below to subscribe to our…

15. Adrenomedullin Therapy in Moderate to Severe COVID-19

Kita

16. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavorable outcomes after cardiac surgery.

van Lier

17. Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort

Soussi

18. Biologically Active Adrenomedullin (bio-ADM) is of potential value in identifying congestion and selecting patients for neurohormonal blockade in acute dyspnea

Simonavičius

19. New Insights in the Control of Fat Homeostasis: The Role of Neurotensin

Barchetta

20. Pro-Enkephalin and its association with renal function in Middle Eastern immigrants and native Swedes

Nilsson